Hillary Clinton decried the effects of some activist investors, calling out firms that have seen involvement from Carl Icahn and others.» Read More
Initial bids for Qwest Communications' long-distance business are below the $2 billion to $3 billion the telecommunications company sought, The Wall Street Journal reported Thursday.
In less than two weeks, there've been four pretty significant events in biopharma. And, hopefully, after ADA things will begin to settle down a bit for the summer.
The cost of drugs was a hot topic at ASCO this year, especially with the release of the big test results combining two very expensive treatments for lung cancer. The study showed using Avastin from Roche and Genentech and a pill, Tarceva, from OSI Pharmaceuticals, Roche and Genentech slowed down progression of the disease by a little more than a month.
Get ready folks: America is about to own a car company. As of Monday, we the taxpayers will own more than 70 percent of GM. Whether the company will be formally renamed Government Motors remains to be seen. But that’s what it will be.
It's going to be a crazy busy, stressful couple of weeks. A shareholder meeting, a medical meeting, then another shareholder meeting and finally another medical meeting.
Imagine my surprise when I got an email over the weekend from "Diabetic Investor" newsletter editor David Kliff informing me that Amylin Pharmaceuticals is quoting me in a letter to shareholders.
Shortly after Eli Lilly reported way better than expected earnings this morning, Amylin Pharmaceuticals fired a new salvo in its escalating proxy battle with billionaire activist investor Carl Icahn.
Wondering if Carl Icahn is bullish or bearish on stocks right now? Find out!
Once again, activist investor Carl Icahn turns to Fast Money to set the record straight on all the rumors surrounding his wheeling and dealing.
Being an independent studio rather than part of a media conglomerate, isn't helping Lionsgate avoid pink slips. The movie studio announced Friday that it's cutting 45 jobs.
Diabetes drugmaker Amylin Pharmaceuticals is headquartered in San Diego. Like a lot of companies, though, it's incorporated in Delaware. But, if a couple of major shareholders get their way, AMLN could reincorporate in an unlikely state.
Billions in loans were extended to private equity. How deep in the weeds are they? "In many cases they're buried," Icahn tells us in a Web Extra exclusive.
Here’s our Fast Money Final Trade. Instead of stock picks our gang gives you their thoughts on the brave new world that comes after the election.
Ahead of the election, you should know Carl Icahn has a few concerns.
Carl Icahn might be a lot of things, but shy isn’t one of them. If there’s something he doesn’t like, expect to hear about. And there’s something he doesn’t like.
Carl Icahn's recent increased investment in Lions Gate shares isn't the only news resulting from the company's low stock price. On October 10 the stock dipped below $6, triggering a margin call by Merrill Lynch for Vice Chairman Michael Burns, selling 672,000 shares of his stock, 49 percent of his stake in the company, recorded in a Form 4 filed on October 14.
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
If there’s one billionaire investor you don’t want to aggravate its Carl Icahn. What makes us say that? He’s aggravated. Really aggravated. Wait till you see what’s got him going.
We couldn’t talk with legendary investor Carl Icahn and not ask about his portfolio. Here’s what’s got his attention these days.
Fed up with the back room wheeling and dealing on Wall Street? Now you can do something about it, thanks to Carl Icahn.